MedPath

Maternal Cardiovascular Adaption to Pregnancy in IVF Patients Following Frozen Embryo Transfer (FET)

Conditions
Magnetic Resonance Imaging (MRI)
Preeclampsia
IVF
Frozen Embryo Transfer (FET)
Cardiovascular Adaption
Registration Number
NCT06471140
Lead Sponsor
Aalborg University Hospital
Brief Summary

Aim of the study is to explore the effect of a lacking corpus luteum on maternal cardiovascular and metabolic adaption to pregnancy by the use of magnetic resonance imaging (MRI).

Detailed Description

The use of programmed frozen embryo transfer cycle (FET) in IVF women is associated with an increased risk of obstetric complications (pregnancy-induced hypertension, preeclampsia, postpartum hemorrhage and placenta accreta) compared to FET in natural cycle.

The lack of corpus luteum in programmed cycles and the subsequent absence of circulating vasoactive substances may lead to an impaired cardio-vascular adaption to pregnancy and thereby an increased risk of pregnancy-induced hypertension and preeclampsia.

The cardiovascular and metabolic adaption to pregnancy is evaluated throughout pregnancy by use of Magnetic Resonance Imaging (MRI) as well as non-invasive measurements by use of elastography and seismocardiography.

Patients are screened for preeclampsia throughout pregnancy with measurements of blood pressure, urine samples as well as blood samples.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Female
Target Recruitment
75
Inclusion Criteria
  • Autologous embryo transfer in programmed FET-cycle or modified-natural FET-cycle or
  • Planned donor egg transfer in programmed FET-cycle or modified-natural FET-cycle
  • Age < 40 years
  • BMI < 35
  • Primary diagnosis being unexplained infertility, male infertility or tubal factor
  • Singleton blastocyst transfer
Exclusion Criteria
  • PCOS
  • Essential hypertension
  • Diabetes Mellitus (type 1 or 2)
  • Known cardiac disease
  • Antiphospholipid syndrome, Lupus erythematosus, rheumatoid disease
  • Preelampsia, gestational hypertension, gestational diabetes or severe intrauterine growth restriction (IUGR) in any previous pregnancy
  • Smoking
  • Multiple pregnancy
  • Severe claustrophobia or any other contraindications to MRI

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Maternal cardiovascular adaption to pregnancyFrom early pregnancy to six months postpartum
Placental function and fetal oxygenation estimated by longitudinal T2* weighted placental and fetal MRIFrom early pregnancy to six months postpartum
Maternal metabolic adaption to pregnancyFrom early pregnancy to six months postpartum
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aalborg University Hospital

🇩🇰

Aalborg, Denmark

Aalborg University Hospital
🇩🇰Aalborg, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.